Paradigm Biopharmaceuticals confirms knee osteoarthritis pain reduction ahead of phase 3 clinical trial of Zilosul
AustraliaParadigm Biopharmaceuticals confirms knee osteoarthritis pain reduction ahead of phase 3 clinical trial of ZilosuladminApril 6, 202010
AustraliaIronbark Zinc non-executive director Danny Segman purchases more shares in the companyadminApril 6, 202011
AustraliaHavilah Resources welcomes relief measures implemented by South Australian GovernmentadminApril 6, 20207
AustraliaParadigm Biopharmaceuticals confirms knee osteoarthritis pain reduction ahead of phase 3 clinical trial of ZilosuladminApril 6, 202010
More than 15 million children and their families in Yemen, Syria and Gaza set to face COVID-19April 1, 2020
AustraliaPanoramic Resources major shareholder Zeta Resources provides unsecured $8 million loanApril 6, 2020
